-
H.
Vordermeier,
B.
Villarreal-Ramos,
P.
Cockle,
M.
McAulay,
S.
Rhodes,
T.
Thacker,
S.
Gilbert,
H.
McShane,
A.
Hill,
Z.
Xing,
R.
Hewinson
(2009)
Viral Booster Vaccines Improve Mycobacterium bovis BCG-Induced Protection against Bovine Tuberculosis
Infection and Immunity, 77
-
D.
O’hagan,
R.
Rappuoli
(2004)
Novel Approaches to Vaccine Delivery
Pharmaceutical Research, 21
-
P.
Darrah,
Dipti
Patel,
P.
Luca,
R.
Lindsay,
Dylan
Davey,
B.
Flynn,
S.
Hoff,
P.
Andersen,
S.
Reed,
S.
Morris,
M.
Roederer,
R.
Seder
(2007)
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
Nature Medicine, 13
-
(2004)
Novel approaches to vaccine deliv
-
L.
Holten-Andersen,
T.
Doherty,
K.
Korsholm,
P.
Andersen
(2004)
Combination of the Cationic Surfactant Dimethyl Dioctadecyl Ammonium Bromide and Synthetic Mycobacterial Cord Factor as an Efficient Adjuvant for Tuberculosis Subunit Vaccines
Infection and Immunity, 72
-
T.
Lindenstrøm,
E.
Agger,
K.
Korsholm,
P.
Darrah,
C.
Aagaard,
R.
Seder,
I.
Rosenkrands,
P.
Andersen
(2009)
Tuberculosis Subunit Vaccination Provides Long-Term Protective Immunity Characterized by Multifunctional CD4 Memory T Cells1
The Journal of Immunology, 182
-
L.
Ly,
D.
Mcmurray
(2008)
Tuberculosis: vaccines in the pipeline
Expert Review of Vaccines, 7
-
S.
Keating,
P.
Bejon,
T.
Berthoud,
J.
Vuola,
S.
Todryk,
D.
Webster,
Susanna
Dunachie,
V.
Moorthy,
S.
McConkey,
S.
Gilbert,
A.
Hill
(2005)
Durable Human Memory T Cells Quantifiable by Cultured Enzyme-Linked Immunospot Assays Are Induced by Heterologous Prime Boost Immunization and Correlate with Protection against Malaria1
The Journal of Immunology, 175
-
A.
Olsen,
Ann
Williams,
L.
Okkels,
G.
Hatch,
P.
Andersen
(2004)
Protective Effect of a Tuberculosis Subunit Vaccine Based on a Fusion of Antigen 85B and ESAT-6 in the Aerosol Guinea Pig Model
Infection and Immunity, 72
-
D.
Ashford,
E.
Whitney,
P.
Raghunathan,
O.
Cosivi
(2001)
Epidemiology of selected mycobacteria that infect humans and other animals.
Revue scientifique et technique, 20 1
-
P.
Hogarth,
R.
Hewinson,
H.
Vordermeier
(2006)
Development of vaccines against bovine tuberculosis
Journal of Pharmacy and Pharmacology, 58
-
H.
Mittrücker,
U.
Steinhoff,
Anne
Köhler,
Marion
Krause,
Doris
Lazar,
Peggy
Mex,
Delia
Miekley,
S.
Kaufmann
(2007)
Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis
Proceedings of the National Academy of Sciences, 104
-
J.
Davidsen,
I.
Rosenkrands,
D.
Christensen,
A.
Vangala,
Daniel
Kirby,
Y.
Perrie,
E.
Agger,
P.
Andersen
(2005)
Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6'-dibehenate)-a novel adjuvant inducing both strong CMI and antibody responses.
Biochimica et biophysica acta, 1718 1-2
-
D.
Christensen,
K.
Korsholm,
P.
Andersen,
E.
Agger
(2007)
Cationic liposomes as vaccine adjuvants
Expert Review of Vaccines, 10
-
H.
Vordermeier,
K.
Huygen,
Mahavir
Singh,
R.
Hewinson,
Z.
Xing
(2006)
Immune Responses Induced in Cattle by Vaccination with a Recombinant Adenovirus Expressing Mycobacterial Antigen 85A and Mycobacterium bovis BCG
Infection and Immunity, 74
-
Kerstin
Werninghaus,
A.
Babiak,
O.
Gross,
C.
Hölscher,
Harald
Dietrich,
E.
Agger,
J.
Mages,
A.
Mócsai,
H.
Schoenen,
Katrin
Finger,
F.
Nimmerjahn,
Gordon
Brown,
C.
Kirschning,
A.
Heit,
P.
Andersen,
H.
Wagner,
J.
Ruland,
R.
Lang
(2009)
Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRγ–Syk–Card9–dependent innate immune activation
The Journal of Experimental Medicine, 206
-
I.
Rosenkrands,
E.
Agger,
A.
Olsen,
K.
Korsholm,
C.
Andersen,
K.
Jensen,
P.
Andersen
(2005)
Cationic Liposomes Containing Mycobacterial Lipids: a New Powerful Th1 Adjuvant System
Infection and Immunity, 73
-
S.
Kaufmann
(2006)
Envisioning future strategies for vaccination against tuberculosis
Nature Reviews Immunology, 6
-
I.
Orme
(2006)
Preclinical testing of new vaccines for tuberculosis: a comprehensive review.
Vaccine, 24 1
-
B.
Bloom
(1994)
Tuberculosis Pathogenesis, Protection, and Control
-
(2009)
: the past , present and future . Expert Rev
-
P.
Hogarth,
K.
Logan,
H.
Vordermeier,
Mahavir
Singh,
R.
Hewinson,
M.
Chambers
(2005)
Protective immunity against Mycobacterium bovis induced by vaccination with Rv3109c--a member of the esat-6 gene family.
Vaccine, 23 20
-
N.
Andrews,
R.
Borrow,
E.
Miller
(2003)
Validation of Serological Correlate of Protection for Meningococcal C Conjugate Vaccine by Using Efficacy Estimates from Postlicensure Surveillance in England
Clinical and Vaccine Immunology, 10
-
(2008)
Tuberculosis : vaccines in the pipeline . Expert Rev
-
Karen
Korsholm,
E.
Agger,
C.
Foged,
D.
Christensen,
J.
Dietrich,
C.
Andersen,
C.
Geisler,
P.
Andersen
(2007)
The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes
Immunology, 121
-
(2004)
for tuberculosis : a comprehensive review
-
A.
Whelan,
D.
Wright,
M.
Chambers,
Mahavir
Singh,
R.
Hewinson,
H.
Vordermeier
(2008)
Evidence for enhanced central memory priming by live Mycobacterium bovis BCG vaccine in comparison with killed BCG formulations.
Vaccine, 26 2
-
W.
Waters,
M.
Palmer,
B.
Nonnecke,
T.
Thacker,
C.
Scherer,
D.
Estes,
R.
Hewinson,
H.
Vordermeier,
S.
Barnes,
Glenn
Federe,
J.
Walker,
R.
Glynne,
Tsungda
Hsu,
Brian
Weinrick,
Karolin
Biermann,
M.
Larsen,
W.
Jacobs
(2009)
Efficacy and immunogenicity of Mycobacterium bovis DeltaRD1 against aerosol M. bovis infection in neonatal calves.
Vaccine, 27 8
-
(2004)
Novel approaches to vaccine
-
H.
Vordermeier,
Mark
Chambers,
P.
Cockle,
A.
Whelan,
J.
Simmons,
R.
Hewinson
(2002)
Correlation of ESAT-6-Specific Gamma Interferon Production with Pathology in Cattle following Mycobacterium bovis BCG Vaccination against Experimental Bovine Tuberculosis
Infection and Immunity, 70
-
(2009)
DISTINCT IMMUNE PHENOTYPES IN A TB VACCINE MODEL
-
S.
Su,
P.
Silver,
R.
Grajewski,
R.
Agarwal,
Jun
Tang,
C.
Chan,
R.
Caspi
(2005)
Essential Role of the MyD88 Pathway, but Nonessential Roles of TLRs 2, 4, and 9, in the Adjuvant Effect Promoting Th1-Mediated Autoimmunity
The Journal of Immunology, 175
-
H.
Vordermeier,
R.
Pontarollo,
B.
Karvonen,
P.
Cockle,
R.
Hecker,
Mahavir
Singh,
L.
Babiuk,
R.
Hewinson,
S.
Hurk
(2005)
Synthetic peptide vaccination in cattle: induction of strong cellular immune responses against peptides derived from the Mycobacterium bovis antigen Rv3019c.
Vaccine, 23 35
-
W.
Reece,
M.
Pinder,
P.
Gothard,
P.
Milligan,
K.
Bojang,
T.
Doherty,
M.
Plebanski,
P.
Akinwunmi,
S.
Everaere,
K.
Watkins,
G.
Voss,
N.
Tornieporth,
A.
Alloueche,
B.
Greenwood,
K.
Kester,
K.
McAdam,
Joe
Cohen,
A.
Hill
(2004)
A CD4+ T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease
Nature Medicine, 10
-
A.
Gavin,
K.
Hoebe,
B.
Duong,
T.
Ota,
Christopher
Martin,
B.
Beutler,
D.
Nemazee
(2006)
Adjuvant-Enhanced Antibody Responses in the Absence of Toll-Like Receptor Signaling
Science, 314
-
J.
Langermans,
T.
Doherty,
R.
Vervenne,
T.
Laan,
K.
Lyashchenko,
R.
Greenwald,
E.
Agger,
C.
Aagaard,
Horst
Weiler,
D.
Soolingen,
W.
Dalemans,
A.
Thomas,
P.
Andersen
(2005)
Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6.
Vaccine, 23 21
-
B.
Bloom,
P.
Fine
(1994)
The BCG Experience: Implications for Future Vaccines against Tuberculosis
-
Jun
Wang,
Z.
Xing
(2002)
Tuberculosis vaccines: the past, present and future
Expert Review of Vaccines, 1
-
E.
Agger,
I.
Rosenkrands,
J.
Hansen,
K.
Brahimi,
Brian
Vandahl,
C.
Aagaard,
Kerstin
Werninghaus,
C.
Kirschning,
R.
Lang,
D.
Christensen,
M.
Theisen,
Frank
Follmann,
P.
Andersen
(2008)
Cationic Liposomes Formulated with Synthetic Mycobacterial Cordfactor (CAF01): A Versatile Adjuvant for Vaccines with Different Immunological Requirements
PLoS ONE, 3
-
B.
Thiers
(2008)
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
Yearbook of Dermatology and Dermatologic Surgery, 2008